| Crizotinib |
ENSG00000163364.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000170919.11 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000172250.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000174171.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000175701.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000177337.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000177822.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000178412.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000178440.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000180139.10 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000182310.8 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000185186.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000185203.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000187156.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000188185.7 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000188825.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000189149.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000189419.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000197099.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000197670.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000203593.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000203808.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000204380.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000204791.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000204934.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000204934.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000205037.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000205500.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000205559.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000205913.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000206417.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000212163.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000212978.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000213742.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000213793.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000213904.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000213971.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000214353.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000214401.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000214548.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000217258.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000219665.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000221817.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000222044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000223379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000223393.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000223462.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000223478.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000223695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000223697.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000223711.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000223745.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000223834.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000223882.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000223891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000223946.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000224023.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000224079.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000224216.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000224269.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000224635.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000224707.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000224707.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000224729.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000224746.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000224764.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000224789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000224794.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000224857.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000224883.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000224888.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000224914.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000224950.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000224965.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000224969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000224977.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000225206.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000225235.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000225235.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000225331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000225465.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000225490.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000225527.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000225572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000225595.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000225703.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000225703.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000225703.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000225721.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000225742.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000225761.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000225839.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000225981.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000226047.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000226200.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000226245.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000226291.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000226291.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000226381.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000226381.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000226386.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000226471.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000226505.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000226609.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000226747.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000226803.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000226889.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000226904.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000226957.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000227076.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000227155.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000227214.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000227256.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000227258.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000227297.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000227456.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000227484.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000227495.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000227502.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000227542.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000227627.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000227698.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000227704.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000227719.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000227719.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000227740.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000227769.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000227857.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000228107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000228126.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000228172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000228222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000228237.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000228302.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000228369.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000228412.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000228540.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000228573.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000228629.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000228634.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000228784.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000228802.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000228802.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000228812.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000228838.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000229190.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000229214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000229263.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000229311.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000229331.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000229463.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000229525.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000229618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000229645.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000229702.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000229727.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000229841.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000229848.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000229867.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000229951.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000229952.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000230046.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000230091.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000230107.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000230131.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000230337.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000230439.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000230555.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000230606.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000230628.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000230630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000230658.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000230736.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000230747.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000230747.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000230753.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000230798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000230826.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000230826.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000230912.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000230943.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000231024.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000231025.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000231119.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000231187.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000231201.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000231242.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000231298.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000231355.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000231473.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000231507.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000231527.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000231566.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000231607.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000231611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000231636.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000231690.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000231704.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000231709.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000231728.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000231728.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000231770.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000231816.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000231840.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000231842.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000231865.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000231889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000231890.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000231912.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000231944.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000232018.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000232019.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000232065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000232093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000232162.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000232211.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000232259.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000232406.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000232412.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000232480.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000232542.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000232564.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000232586.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000232593.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000232623.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000232640.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000232642.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000232648.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000232694.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000232725.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000232811.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000232956.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000233006.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000233006.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000233184.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000233368.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000233411.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000233483.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000233547.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000233554.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000233559.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000233755.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000233757.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000233791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000233848.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000233852.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000233895.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000233903.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000233903.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000234019.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000234028.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000234141.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000234171.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000234206.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000234215.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000234232.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000234264.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000234290.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000234327.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000234432.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000234492.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000234494.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000234509.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000234572.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000234608.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000234705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000234884.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000235070.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000235078.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000235119.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000235123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000235131.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000235314.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000235358.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000235358.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000235387.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000235501.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000235530.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000235560.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000235652.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000235659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000235703.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000235706.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000235781.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000235802.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000235872.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000235919.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000236017.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000236088.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000236137.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000236166.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000236173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000236255.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000236404.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000236537.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000236559.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000236658.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000236682.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000236751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000236751.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000236859.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000236861.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000236871.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000237125.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000237149.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000237200.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000237520.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000237525.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000237529.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000237594.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000237605.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000237718.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000237797.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000237870.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000237892.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000238005.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000238121.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000238198.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000238280.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000239377.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000239523.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000239552.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000239911.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000240006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000240207.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000240211.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000240373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000240476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000240549.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000240549.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000240618.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000240859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000240875.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000241316.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000241481.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000241764.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000241954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000242147.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000242622.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000243433.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000243485.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000243766.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000244203.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000244265.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000244268.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000244300.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000244310.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000244349.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000244468.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000244586.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000244968.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000245275.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000245330.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000245479.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000245522.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000245534.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000245552.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000246095.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000246145.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000246250.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000246263.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000246363.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000247092.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000247137.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000247213.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000247774.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000248008.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000248103.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000248223.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000248356.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000248468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000248677.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000248773.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000248858.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000248896.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000248927.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000249198.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000249436.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000249595.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000249602.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000249628.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000249635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000249740.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000249740.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000249807.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000249816.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000249846.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000250027.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000250295.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000250337.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000250404.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000250413.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000250592.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000250659.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000250751.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000250948.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000251022.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000251127.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000251136.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000251556.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000251629.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000251687.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000253121.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000253190.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000253535.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000253618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000253632.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000253653.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000253696.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000253733.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000253764.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000253773.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000253865.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000253948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000254237.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000254258.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000254295.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000254315.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000254401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000254418.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000254419.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000254428.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000254477.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000254485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000254662.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000254777.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000254821.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000254826.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000254842.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000254854.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000254855.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000254859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000254929.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000254964.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000254966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000254966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000255092.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000255142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000255197.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000255306.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000255308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000255321.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000255334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000255354.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000255980.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000255989.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000256001.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000256008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000256250.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000256299.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000256442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000256596.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000256705.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000256712.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000256712.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000256789.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000256897.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000256967.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000256973.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000257135.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000257167.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000257272.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000257303.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000257433.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000257438.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000257474.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000257543.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000257556.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000257711.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000257742.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000257815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000257900.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000257910.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000257931.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000258188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000258314.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000258317.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000258378.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000258410.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000258437.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000258443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000258450.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000258458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000258521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000258558.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000258623.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000258663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000258725.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000258731.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000258777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000258777.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000258789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000258843.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000258851.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000258851.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000258920.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000258929.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000258942.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000259062.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000259065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000259083.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000259118.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000259153.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000259158.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000259198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000259200.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000259212.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000259244.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000259248.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000259364.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000259366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000259553.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000259584.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000259617.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000259644.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000259656.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000259668.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000259673.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000259687.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000259732.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000259736.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000259768.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000259786.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000259804.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000259818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000259901.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000259943.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000259959.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000260005.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000260060.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000260063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000260081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000260083.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000260158.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000260196.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000260197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000260261.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000260317.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000260331.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000260352.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000260423.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000260441.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000260447.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000260475.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000260526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000260552.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000260597.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000260613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000260630.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000260633.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000260693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000260708.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000260778.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000260793.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000260805.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000260830.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000260853.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000260896.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000260911.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000260924.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000260936.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000260938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000260947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000261000.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000261019.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000261043.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000261131.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000261173.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000261212.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000261251.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000261253.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000261254.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000261266.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000261327.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000261346.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000261373.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000261386.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000261416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000261430.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000261433.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000261441.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000261455.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000261471.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000261476.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000261481.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000261504.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000261526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000261572.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000261578.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000261616.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000261654.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000261712.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000261754.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000261777.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000261783.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000262098.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000262171.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000262185.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000262185.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000262202.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000262228.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000262228.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000262298.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000262339.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000262686.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000262692.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000262777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000262873.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000262903.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000262999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000263105.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000263300.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000263466.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000263499.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000263612.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000263745.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000263874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000263884.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000264043.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000264112.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000264167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000264207.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000264247.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000264339.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000264448.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000264491.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000264635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000264729.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000264808.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000264860.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000264940.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000265394.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000265445.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000265519.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000265542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000265656.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000265739.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000265780.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000265800.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000266079.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000266120.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000266579.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000266667.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000266783.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000266844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000266895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000266908.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000266926.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000266930.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000266983.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000267010.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000267040.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000267053.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000267067.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000267067.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000267096.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000267100.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000267167.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000267219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000267232.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000267244.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000267265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000267274.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000267277.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000267298.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000267344.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000267348.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000267395.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000267416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000267446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000267476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000267479.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000267613.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000267654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000267655.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000267705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000267731.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000267759.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000267787.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000267898.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000268316.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000268366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000268530.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000268613.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000268746.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000268970.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000268987.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000269038.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000269051.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000269091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000269107.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000269161.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000269161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000269194.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000269246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000269321.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000269387.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000269392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000269399.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000269423.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000269444.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000269646.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000269836.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000269893.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000269946.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000269951.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000269956.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000269959.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000269966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000270062.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000270081.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000270083.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000270091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000270107.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000270109.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000270159.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000270178.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000270195.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000270482.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000270522.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000270581.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000270605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000270742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000270828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000270988.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000271185.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000271185.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000271234.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000271344.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000271382.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000271401.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000271417.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000271752.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000271755.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000271762.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000271788.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000271825.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000271833.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000271840.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000271882.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000271964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000271981.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000272003.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000272009.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000272029.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000272092.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000272092.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000272102.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000272109.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000272142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000272143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000272211.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000272219.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000272248.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000272254.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000272265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000272316.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000272327.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000272338.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000272377.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000272377.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000272420.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000272461.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000272508.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000272524.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000272558.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000272562.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000272635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000272635.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000272663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000272663.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000272691.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000272695.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000272702.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000272702.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000272702.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000272717.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000272735.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000272792.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000272800.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000272812.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000272871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000272888.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000272931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000272966.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000272966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000272989.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000272989.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000273004.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000273015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000273065.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000273071.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000273073.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000273084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000273162.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000273174.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000273179.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000273230.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000273281.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000273297.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Crizotinib |
ENSG00000273308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000273309.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Crizotinib |
ENSG00000273399.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Crizotinib |
ENSG00000273428.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Crizotinib |
ENSG00000273437.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
ENSG00000273486.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Crizotinib |
miR-150 |
Curated miRNA |
anaplastic large-cell lymphoma |
|
